CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: DR. KHALID MUBARAK AL-SHAFI

Life Style / Wellness

Covid raises clotting risks for months after even mild infection 07 Apr 2022 - 10:08 am
Peninsula
Current COVID vaccines not 'well-matched' against BA.2: FDA 06 Apr 2022 - 05:04 pm
Peninsula
Global groups propose pandemic plan costing $10 billion a year 05 Apr 2022 - 06:11 pm
Reuters file photo
WHO suspends procurement, supply of Bharat Biotech Covid vaccine 03 Apr 2022 - 07:38 pm
Peninsula
New bed nets that 'ground' mosquitoes could boost malaria fight 25 Mar 2022 - 05:59 pm
Anopheles mosquitoes are seen in a net placed in a rice field during a test in the use of drone technology in the fight against malaria near Zanzibar City, on the island of Zanzibar, Tanzania, October 30, 2019. REUTERS/Baz Ratner
Moderna seeks FDA authorization for second COVID booster for all adults 18 Mar 2022 - 01:33 pm
Peninsula
Top Pfizer and Moderna executives diverge on need for fourth Covid shot 15 Mar 2022 - 12:29 pm
Peninsula
Moderna starts study of hybrid vaccine that targets Omicron 10 Mar 2022 - 09:28 pm
Peninsula
WHO says Covid boosters needed, reversing previous call 08 Mar 2022 - 08:00 pm
Peninsula
COVID-19 can cause brain shrinkage, memory loss: Study 08 Mar 2022 - 10:54 am
File photo
Death toll nears 6 million as pandemic enters its 3rd year 06 Mar 2022 - 06:14 pm
Corpses are moved to a refrigerated container outside a funeral home, as mortuaries run out of space amid the coronavirus disease (COVID-19) outbreak in Hong Kong, China, March 5, 2022. REUTERS/Tyrone Siu
Almost a third of people report lingering symptom 6-12 months after COVID-19 -study 04 Mar 2022 - 08:31 pm
Peninsula
Researchers discover cause of sleeping problems among elderly 01 Mar 2022 - 03:42 pm
Representational purpose
Recent study finds vegetables alone not enough to reduce heart risk 22 Feb 2022 - 12:56 pm
Peninsula
Exercise boosts the brain and mental health 20 Feb 2022 - 02:27 pm
Peninsula
Gilead says COVID drug remdesivir shows antiviral activity against Omicron, other variants 11 Feb 2022 - 06:18 pm
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo
J&J pauses production of its COVID-19 vaccine - NYT 08 Feb 2022 - 08:39 pm
Peninsula
Omicron-specific booster may not be needed, U.S. monkey study finds 05 Feb 2022 - 02:28 pm
Peninsula